Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Dizziness, Fatigue, Inappropriate schedule of product administration
Clinical narrative: Less than 26 days between first and second dose; Fever; Her arm hurt; Dizziness; Loss of appetite; Chills; Felt tired; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), MYALGIA (Her arm hurt), DIZZINESS (Dizziness), DECREASED APPETITE (Loss of appetite) and CHILLS (Chills) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concomitant products included VITAMIN D [VITAMIN D NOS], VITAMIN E NOS and CENTRUM FOR WOMEN for an unknown indication.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced PYREXIA (Fever), MYALGIA (Her arm hurt), DIZZINESS (Dizziness), DECREASED APPETITE (Loss of appetite), CHILLS (Chills) and FATIGUE (Felt tired). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Less than 26 days between first and second dose). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 11-Apr-2021, PYREXIA (Fever), MYALGIA (Her arm hurt), DIZZINESS (Dizziness), DECREASED APPETITE (Loss of appetite), CHILLS (Chills) and FATIGUE (Felt tired) had resolved. At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Less than 26 days between first and second dose) outcome was unknown. Not Provided          This case was linked to US-MODERNATX, INC.-MOD-2021-077099 (E2B Linked Report). This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Apr-2021 and was forwarded to Moderna on 14-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), MYALGIA (Her arm hurt), DIZZINESS (Dizziness), DECREASED APPETITE (Loss of appetite) and CHILLS (Chills) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was reported.  Concomitant products included VITAMIN D [VITAMIN D NOS], VITAMIN E NOS and CENTRUM FOR WOMEN for an unknown indication.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced PYREXIA (Fever), MYALGIA (Her arm hurt), DIZZINESS (Dizziness), DECREASED APPETITE (Loss of appetite), CHILLS (Chills) and FATIGUE (Felt tired). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Less than 26 days between first and second dose). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 11-Apr-2021, PYREXIA (Fever), MYALGIA (Her arm hurt), DIZZINESS (Dizziness), DECREASED APPETITE (Loss of appetite), CHILLS (Chills) and FATIGUE (Felt tired) had resolved. At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Less than 26 days between first and second dose) outcome was unknown. Not Provided          This case was linked to US-MODERNATX, INC.-MOD-2021-077099 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077099:Crossed linked